Our become a distributor page covers the commercial terms for a new distributor. This page covers what actually changes once you are inside the programme and buying on a recurring basis.
Who the programme is for
- Licensed pharmaceutical distributors with an existing institutional and clinical customer base
- Regional wholesalers who want a research-grade line that complements a finished-formulation book
- Institutional supply partners serving laboratories, CROs and hospital procurement
- Export distributors with an established market in a territory we do not cover directly
All applicants are subject to drug licence verification, and the programme is strictly business-to-business. We do not appoint individual resellers or retail sellers.
What you get
| Benefit | Detail |
|---|---|
| Contract-band pricing | Agreed pricing across the term, protected from spot movement, with volume breaks defined at the outset |
| Territory protection | Agreed territory for the duration of the agreement. We will not appoint a second distributor in an area already served, and we do not sell directly into it |
| Scheduled supply | Monthly or quarterly deliveries against an agreed forecast, with reserved capacity on constrained sequences |
| Full documentation pack | Every consignment ships with the complete document set — COA with chromatogram, mass spectrometry, MSDS, Certificate of Origin and the rest. Nothing is withheld behind a "request" |
| Named account manager | One point of contact who knows your specification, your buyer pattern and your documentation requirements |
| Standing document template | Your required format, accepted once and applied to every shipment, so your customs broker never has to re-check |
| Priority allocation | First call on limited synthesis capacity and on scheduled synthesis slots |
| Credit terms | Available once the trading pattern is established |
| Custom synthesis access | Route to custom synthesis and API-scale supply through the same agreement |
What we ask of a distributor
The arrangement works because it is mutual. A distributor partner is expected to:
- Hold and maintain valid drug licensing appropriate to their market
- Sell only to licensed, qualified buyers — never to unqualified end users
- Maintain the RUO (research use only) designation on all downstream material and documentation
- Forward the batch COA with every delivery, unaltered
- Route any buyer query on quality, specification or documentation to us rather than answering it independently
- Flag any lot that fails third-party verification, so we can act on it
- Maintain a rolling forecast so scheduled supply can be planned
We will not appoint a partner who cannot meet those points. It protects the network, and it protects you.
How to apply
- Send your company details — registration, drug licence, IEC, and a short description of your business and your end markets
- Tell us the volume you expect to move and the SKUs you intend to start with. Starting with three to five SKUs and a defined monthly quantity works better than a broad catalogue commitment
- Qualify on a first order under standard trade terms. This is deliberate — it confirms your downstream process before either of us is committed
- Sign the distribution agreement, covering territory, volume commitments, pricing, documentation obligations, compliance representations and term
- Move to contract band once the reorder pattern is established, typically after two or three qualifying orders
Applications are assessed on business substance rather than on a queue position. A distributor who can move 50 vials a month of one sequence is more useful to us than one who expects to move two of twenty.
What we do not do
We do not appoint a distributor to sell on our behalf into a territory we serve directly. We do not grant exclusivity beyond an agreed territory. We do not supply material for human or veterinary use under any circumstances. And we do not provide marketing materials that make therapeutic claims — the material is research-grade and the documentation reflects that.
Ready to apply? Send your company details and expected volume to the trade desk and we will come back with the terms for your case.
B2B trade only — request a quote
All peptides are research-grade, for in-vitro use only, and supplied against a valid drug licence. Tell us your sequence, quantity and destination and the trade desk will respond within one business day.